World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms (News)

World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms

Griffith News
14 July 2021
https://news.griffith.edu.au/2021/07/14/world-first-laboratory-study-finds-low-dose-naltrexone-may-improve-me-cfs-symptoms/

Published in the journal Frontiers in Immunology, the researchers found that patients with ME/CFS taking low-dose Naltrexone (LDN 3.0-5.0mg/day) show significant improvements in cell function in a laboratory study using a model of natural killer (NK) cells from patients.